Drug Class: Melanocortin Receptor Agonist
Composition: Bremelanotide
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
Laboratory Test: View Lab Report
For Subcutaneous Injection
For bodybuilders, fitness enthusiasts, and anyone looking to revitalize their sexual health, Peptide Hubs PT-141 (Bremelanotide) offers a revolutionary approach. Unlike traditional solutions that work on hormones or blood flow, PT-141 directly targets the central nervous system to activate sexual arousal pathways. This 10 mg vial of high-purity, lab-tested lyophilized powder is your key to unlocking a powerful, reliable, and on-demand libido boost for both men and women, helping you overcome the sexual side effects often associated with intense training cycles or lifestyle stress.
PT-141 is a synthetic peptide analog of α-MSH (alpha-melanocyte-stimulating hormone). It is a metabolite of the well-known peptide Melanotan 2, but with a crucial difference: it has been specifically engineered to enhance libido without the strong melanotropic (tanning) effects. It was developed from research into Melanotan II and gained attention for its ability to treat sexual dysfunction in both sexes. Its mechanism of action is unique; it bypasses the hormonal pathways and acts directly on melanocortin receptors in the central nervous system, particularly in the hypothalamus, which is responsible for regulating sexual arousal. The U.S. Food and Drug Administration (FDA) approved Bremelanotide (under the brand name Vyleesi) in 2019 for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), validating its powerful effect on female libido.
The effects of PT-141 are primarily neurological, leading to profound physiological and psychological changes related to sexual function. Users report a significant and often spontaneous increase in libido and improvement in sexual performance.
PT-141 is supplied as a lyophilized powder that must be reconstituted with Bacteriostatic Water before subcutaneous (SubQ) injection. Intramuscular (IM) injection is not common for this peptide.
Reconstitution Guide:
Dosing Recommendations:
Administration Timing: Inject subcutaneously into the abdomen or thigh approximately 4-6 hours before sexual activity. The effects can last for up to 12-24 hours, with the peak effects typically felt within the first few hours.
PT-141 is not a peptide for daily use. It is an "on-demand" product used in conjunction with planned sexual activity. However, it can be strategically combined with other peptides to create a comprehensive wellness and performance stack that addresses both sexual health and overall physical conditioning.
PT-141 is generally well-tolerated, but its unique mechanism of action can produce some transient side effects. These are almost always dose-dependent and can be minimized by starting with a low dose.
Contraindication: PT-141 is not recommended for individuals with cardiovascular disease or uncontrolled high blood pressure. It should not be used by pregnant or nursing women.
Name: Bremelanotide
Drug Class: Melanocortin Receptor Agonist
Other common names and terms: PT-141, Vyleesi (pharmaceutical brand)
Active Life: 4-6 hours (primary effects), up to 24 hours (residual effects)
Detection Time: Not well established, estimated 24-48 hours
Chemical Structure: Synthetic heptapeptide analog of α-MSH
Common Doses: 0.5 mg - 2.0 mg, as needed
Blood pressure: May cause a temporary, mild increase
Acne: None
Water retention: None
Aromatisation: Does not aromatize
Liver toxicity: None
Decrease HPTA function: No, it is non-hormonal
PT-141 has a relatively fast onset of action. Most users begin to feel the initial effects, such as spontaneous stretching or a slight flush, within 1-2 hours. The peak libido-enhancing effects are typically experienced between 3 to 6 hours after a subcutaneous injection. For optimal results, it is recommended to administer PT-141 approximately 4-6 hours before planned sexual activity.
Absolutely. PT-141 is highly effective for women and was officially FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women under the brand name Vyleesi. Women report a significant increase in spontaneous sexual thoughts, desire, and overall arousal. The dosing for women is similar to men, typically starting at 0.5-1.0 mg and finding an effective dose between 1.0-1.75 mg.
While PT-141 is a metabolite of Melanotan 2 (MT2), they have distinct primary effects. Melanotan 2 is primarily used for skin tanning and has strong libido-enhancing effects as a significant side effect. PT-141 was developed by isolating and modifying the structure to remove most of the melanotropic (tanning) activity while retaining and enhancing the libido effects. If your primary goal is sexual enhancement without tanning, PT-141 is the superior and more targeted choice.
PT-141 is designed for on-demand, intermittent use. It is not intended for daily administration. To minimize the potential for building a tolerance and to manage side effects, it is recommended to use it no more than 2-3 times per week, with at least one day between doses. Frequent, long-term daily use is not well-studied and is not advised.
Nausea is the most common side effect but is often manageable. To reduce its likelihood and severity: 1) Always start with a low dose (0.5 mg) to assess your tolerance. 2) Inject on a completely empty stomach, waiting at least 2 hours after a meal. 3) Stay well-hydrated before and after injection. 4) For many users, the nausea diminishes or disappears entirely after the first few uses as the body acclimates. Avoid taking anti-nausea medication unless directed by a doctor.
Please log in to write PT-141 10 mg review.
For Intramuscular Injection
Composition:
- Testosterone Propionate 42 mg
- Testosterone Phenylropionate 84 mg
- Testosterone Isocaproate 84 mg
- Testosterone Decanoate 140 mg
Mixed Dosage: 350 mg/1 mL
Unit: 10 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals